Octant (Series A)
Funding Details
Awarder
Inbox
Date Award
May 20, 2020
Vertical
Synthetic Biology
Funding Amount
$30,000,000
Company Info
Organizations Involved
Bristol-Myers Squibb, Catalio Capital Management
Founders
Sri Kosuri
Market
Drug Discovery
Location
Emeryville, CA, USA
Coinvestors
Allen & Company, SV Angel
Company Description

Octant is a synthetic-biology drug discovery company designing multi-target drug leads for multifactorial diseases. Octant engineers biology, using living cells as high-throughput data networks to map, measure and model compound reactions against GPCRs and ultimately, the entire universe of human receptors.

Links